ctrl K

Price Alert

EyeGate Pharmaceuticals I... (EYEG)

NASDAQ: EYEG · Real-Time Price · USD

35.65

-0.06 (-0.17%)

At close: Aug 20, 2025, 9:30 AM

35.73

0.22%

After-hours: Aug 20, 2025, 04:04 PM EDT

EyeGate Pharmaceuticals Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	16M	16.02M	16.02M	20K	20K	12.06K	12.06K	12.06K
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	-20K	n/a	n/a	20K	20K	12.06K	12.06K	12.06K
Operating Income	785.42K	636.73K	2.97M	-6.15M	-2.54M	-10.81M	-9.85M	-8.82M
Interest Income	1.25M	1.25M	1.25M	n/a	n/a	806.00	1.14K	5.14K
Pretax Income	6.51M	6.56M	8.63M	-5.63M	-2.22M	-10.42M	-9.46M	-8.71M
Net Income	4.69M	4.62M	6.81M	-5.63M	-2.22M	-10.43M	-9.47M	-8.72M
Selling & General & Admin	5.51M	5.69M	4.2M	2.92M	1.54M	5.46M	5.14M	4.93M
Research & Development	10.43M	8.75M	6.21M	2.22M	906.68K	5.36M	4.72M	3.91M
Other Expenses	904.01K	1.02M	1.02M	1.02M	120.23K	n/a	n/a	n/a
Operating Expenses	16.84M	15.46M	11.44M	6.17M	2.56M	10.82M	9.86M	8.83M
Interest Expense	-21.45K	-21.45K	-21.45K	n/a	n/a	6.91K	6.91K	4.87K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	8.88M	11.44M	11.44M	6.17M	2.56M	10.82M	9.86M	8.83M
Income Tax Expense	-2.08M	-2.19M	-2.07M	n/a	n/a	509.00	581.00	4.92K
Shares Outstanding (Basic)	3.99M	4.22M	3.87M	4.21M	4.17M	7.06M	7.06M	6.95M
Shares Outstanding (Diluted)	3.99M	4.22M	4.13M	4.21M	4.17M	7.06M	7.06M	6.95M
EPS (Basic)	0.82	0.83	1.35	-1.34	-0.53	-1.67	-1.69	-1.72
EPS (Diluted)	0.76	0.77	1.29	-1.34	-0.53	-1.67	-1.69	-1.72
EBITDA	5.9M	5.75M	8.08M	-6.15M	-2.54M	-10.38M	-9.42M	-8.68M
EBIT	n/a	n/a	n/a	n/a	n/a	-10.41M	-9.45M	-8.71M
Depreciation & Amortization	-11.06K	-11.06K	-11.06K	n/a	n/a	43.32K	40.9K	36.93K